|
Pulmonary Hypertension Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 120 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Pulmonary Hypertension Global Clinical Trials Review, H1, 2012" provides data on the Pulmonary Hypertension clinical trial scenario. This report prov.....
Introduction GlobalData's clinical trial report, “Pulmonary Hypertension Global Clinical Trials Review, H1, 2012" provides data on the Pulmonary Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pulmonary Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pulmonary Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 7 Introduction 8 Pulmonary Hypertension 8 Report Guidance 8 Clinical Trials by Region 9 Clinical Trials by Country 10 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12 Top Five Countries Contributing to Clinical Trials in Europe 13 Top Countries Contributing to Clinical Trials in North America 14 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15 Top Five Countries Contributing to Clinical Trials in Central and South America 16 Clinical Trials by BRIC Nations 17 Clinical Trials by G7 Nations 18 Clinical Trials in G7 Nations by Trial Status 19 Clinical Trials by E7 Nations 20 Clinical Trials in E7 Nations by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Unaccomplished Trials of Pulmonary Hypertension 25 Subjects Recruited Over a Period of Time 31 Prominent Sponsors 32 Top Companies Participating in Pulmonary Hypertension Therapeutics Clinical Trials 34 Prominent Drug Comparison 36 Clinical Trial Profiles 37 Clinical Trial Overview of Top Companies 37 Actelion Ltd 37 Clinical Trial Overview of Actelion Ltd 37 Pfizer Inc. 40 Clinical Trial Overview of Pfizer Inc. 40 United Therapeutics Corporation 43 Clinical Trial Overview of United Therapeutics Corporation 43 Bayer AG 45 Clinical Trial Overview of Bayer AG 45 Gilead Sciences, Inc. 47 Clinical Trial Overview of Gilead Sciences, Inc. 47 GlaxoSmithKline plc 48 Clinical Trial Overview of GlaxoSmithKline plc 48 Novartis AG 49 Clinical Trial Overview of Novartis AG 49 Eli Lilly and Company 50 Clinical Trial Overview of Eli Lilly and Company 50 Lung Rx, Inc. 51 Clinical Trial Overview of Lung Rx, Inc. 51 INO Therapeutics, LLC 52 Clinical Trial Overview of INO Therapeutics, LLC 52 AstraZeneca PLC 53 Clinical Trial Overview of AstraZeneca PLC 53 EPIX Pharmaceuticals, Inc. (Inactive) 54 Clinical Trial Overview of EPIX Pharmaceuticals, Inc. (Inactive) 54 Nippon Shinyaku Co., Ltd. 55 Clinical Trial Overview of Nippon Shinyaku Co., Ltd. 55 GENO Pharmaceuticals Ltd. 56 Clinical Trial Overview of GENO Pharmaceuticals Ltd. 56 Encysive Pharmaceuticals Inc. 57 Clinical Trial Overview of Encysive Pharmaceuticals Inc. 57 Berlin Chemi AG 58 Clinical Trial Overview of Berlin Chemi AG 58 Children's Healthcare of Atlanta Inc. 59 Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 59 Medtronic Cardiac Rhythm Disease Management 60 Clinical Trial Overview of Medtronic Cardiac Rhythm Disease Management 60 Clinical Trial Overview of Top Universities / Institutes / Hospitals 61 University of Heidelberg 61 Clinical Trial Overview of University of Heidelberg 61 Keio University 62 Clinical Trial Overview of Keio University 62 Assistance Publique - Hopitaux de Paris 63 Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 63 University of California, Los Angeles 64 Clinical Trial Overview of University of California, Los Angeles 64 The Medical University of Graz 65 Clinical Trial Overview of The Medical University of Graz 65 The University of Chicago 66 Clinical Trial Overview of The University of Chicago 66 North Shore Long Island Jewish Health System 67 Clinical Trial Overview of North Shore Long Island Jewish Health System 67 University of Cincinnati 68 Clinical Trial Overview of University of Cincinnati 68 The Cleveland Clinic 69 Clinical Trial Overview of The Cleveland Clinic 69 Rabin Medical Center 70 Clinical Trial Overview of Rabin Medical Center 70 University of Oxford 71 Clinical Trial Overview of University of Oxford 71 Medical University of Vienna 72 Clinical Trial Overview of Medical University of Vienna 72 Imperial College London 73 Clinical Trial Overview of Imperial College London 73 The Children's Hospital of Philadelphia 74 Clinical Trial Overview of The Children's Hospital of Philadelphia 74 Aarhus University 75 Clinical Trial Overview of Aarhus University 75 Mayo Clinic 76 Clinical Trial Overview of Mayo Clinic 76 Duke University 77 Clinical Trial Overview of Duke University 77 University of California, San Francisco 78 Clinical Trial Overview of University of California, San Francisco 78 Radboud University 79 Clinical Trial Overview of Radboud University 79 Department of Defence 80 Clinical Trial Overview of Department of Defence 80 Five Key Clinical Profiles 81 Appendix 117 Abbreviations 117 Definitions 117 Research Methodology 118 Secondary Research 119 About GlobalData 119 Contact Us 119 Disclaimer 119 Source 120 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9 Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Pulmonary Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12 Pulmonary Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13 Pulmonary Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2012* 14 Pulmonary Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15 Pulmonary Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16 Pulmonary Hypertension Therapeutics Clinical Trials, BRIC Countries, 2012* 17 Pulmonary Hypertension Therapeutics Clinical Trials, G7 Countries, 2012* 18 Pulmonary Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Pulmonary Hypertension Therapeutics Clinical Trials, E7 Countries, 2012* 20 Pulmonary Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22 Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23 Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Pulmonary Hypertension Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25 Pulmonary Hypertension Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26 Pulmonary Hypertension Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27 Pulmonary Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31 Pulmonary Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 33 Pulmonary Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 35 Pulmonary Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2012* 37 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 40 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2012* 43 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 45 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012* 47 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 48 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 49 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 50 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Lung Rx, Inc., 2012* 51 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by INO Therapeutics, LLC, 2012* 52 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 53 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by EPIX Pharmaceuticals, Inc. (Inactive), 2012* 54 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Shinyaku Co., Ltd., 2012* 55 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by GENO Pharmaceuticals Ltd., 2012* 56 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Encysive Pharmaceuticals Inc., 2012* 57 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Berlin Chemi AG, 2012* 58 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Healthcare of Atlanta Inc., 2012* 59 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic Cardiac Rhythm Disease Management, 2012* 60 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2012* 61 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2012* 62 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 63 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 64 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2012* 65 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012* 66 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by North Shore Long Island Jewish Health System, 2012* 67 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2012* 68 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2012* 69 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2012* 70 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2012* 71 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012* 72 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012* 73 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2012* 74 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012* 75 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 76 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 77 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 78 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012* 79 Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Defence, 2012* 80 List of Figures Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9 Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Pulmonary Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12 Pulmonary Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13 Pulmonary Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14 Pulmonary Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15 Pulmonary Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16 Pulmonary Hypertension Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17 Pulmonary Hypertension Therapeutics Clinical Trials, G7 Countries (%), 2012* 18 Pulmonary Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Pulmonary Hypertension Therapeutics Clinical Trials, E7 Countries (%), 2012* 20 Pulmonary Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22 Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23 Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Pulmonary Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31 Pulmonary Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 32 Pulmonary Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 34 Pulmonary Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36 GlobalData Methodology 118 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
